---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-041201"
form_type: "8-K"
ticker: "EIKN"
cik: "0001861123"
company_name: "Eikon Therapeutics, Inc."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:08:26.707227+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Eikon adopts amended charter and bylaws upon IPO closing on Feb 6, 2026

## Summary
- IPO of common stock closed on February 6, 2026 per the company's S-1 registration.
- Amended and restated certificate of incorporation filed with Delaware Secretary of State.
- Amended and restated bylaws adopted effective as of February 6, 2026.
- Both documents were previously approved by the board and stockholders.

## SEC filing metadata
- accession: 0001193125-26-041201
- form_type: 8-K
- ticker: EIKN
- cik: 0001861123
- company_name: Eikon Therapeutics, Inc.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861123/000119312526041201/0001193125-26-041201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861123/000119312526041201/d49647d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-041201
- JSON: https://secwatch.observer/filing/0001193125-26-041201.json
- Plain text: https://secwatch.observer/filing/0001193125-26-041201.txt

## Source-grounded claims
- claim_id: c9104b5be1a55633375dcc399c60124e45a54941
  claim: Eikon Therapeutics, Inc.: Filed an amended and restated certificate of incorporation effective immediately prior to closing of IPO (effective 2026-02-06).
  evidence_excerpt: In connection with the closing of the initial public offering (the “IPO”) of shares of common stock of Eikon Therapeutics, Inc. (the “Company”) on February 6, 2026, the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861123/000119312526041201/0001193125-26-041201-index.htm
- claim_id: d12d3d27e504897ee7bd256c0d48cb4e466c6657
  claim: Eikon Therapeutics, Inc.: Adopted amended and restated bylaws effective as of February 6, 2026, in connection with the closing of the IPO (effective 2026-02-06).
  evidence_excerpt: Effective as of February 6, 2026, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861123/000119312526041201/0001193125-26-041201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.